When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Strongyloides infection

Evidence last reviewed: 25 Jun 2026
Topic last updated: 24 Jul 2026

Summary

Definition

History and exam

Key diagnostic factors

  • history of soil exposure in an endemic area
  • infection with other parasites
Full details

Other diagnostic factors

  • abdominal pain
  • altered bowel habit
  • weight loss
  • fever (hyperinfection)
  • signs of sepsis (hyperinfection)
  • chronic cough
  • wheezing
  • pruritus or dermatitis
  • larva currens
  • urticaria
  • cutaneous larva migrans
  • apparent drug reaction rash (hyperinfection)
  • other skin complaints
  • symptoms and signs of inflammatory bowel disease
  • signs of neurologic manifestations
Full details

Risk factors

  • soil exposure in endemic region or migrantion from an endemic region
  • corticosteroid use (risk of hyperinfection)
  • human T-cell lymphotropic virus type-1 (HTLV-1) infection (risk of hyperinfection)
  • international travelers
  • impaired immunity
  • solid-organ transplant recipient
Full details

Diagnostic tests

1st tests to order

  • stool ova and parasites (O&P) exam
  • CBC with differential
  • therapeutic trial of ivermectin (in specific situations)
Full details

Tests to consider

  • sputum O&P exam
  • clinical sample (nonstool or sputum) O&P exam
  • strongyloides IgG serology
  • tissue biopsy
Full details

Emerging tests

  • polymerase chain reaction (PCR)
  • strongyloides IgG4 urine

Treatment algorithm

INITIAL

immigrant from endemic area

ACUTE

able to tolerate oral therapy: not critically ill (nonpregnant)

unable to tolerate oral therapy or critically ill (nonpregnant)

pregnant

ONGOING

poor clinical response or initial treatment not completed

Contributors

Authors

Louis M. Weiss , MD, MPH

Professor, Department of Pathology

Professor, Department of Medicine (Infectious Diseases)

Albert Einstein College of Medicine

Bronx, NY

Disclosures

LMW has received grant funding from the National Institute of Health for research on Toxoplasma gondii and microsporidiosis. LMW receives training grants for infectious diseases at the Albert Einstein College of Medicine, and serves on the board of the Humane Society of Westchester.

Acknowledgements

Dr Louis M. Weiss would like to gratefully acknowledge Dr David R. Boulware, the previous contributor to this topic. DRB declares that he has no competing interests.

Peer reviewers

Elizabeth Barnett, MD

Professor

Department of Pediatrics

Boston Medical Center

Boston University

Boston, MA

Disclosures

EB declares that she is on a speaker's bureau for Merck.

Linda Nield, MD, FAAP

Professor of Pediatrics

West Virginia University School of Medicine

Morgantown, WV

Disclosures

LN declares that she has no competing interests.

Geoff Gill, MA, MSc, MD, FRCP, DTMH

Professor of International Medicine and Honorary Consultant Physician

Liverpool School of Tropical Medicine

Liverpool

UK

Disclosures

GG declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

World Gastroenterology Organisation. WGO practice guideline: management of strongyloidiasis. February 2018 [internet publication].Full text

Henriquez-Camacho C, Gotuzzo E, Echevarria J, et al. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev. 2016 Jan 18;(1):CD007745.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Use of this content is subject to our disclaimer